3rd Feb 2005 12:39
Skyepharma PLC03 February 2005 For Immediate Release 3 February 2005 SkyePharma PLC ("the Company") Notification of Interests of Directors On 2 February 2005 the following Directors were allocated ordinary shares in theCompany under the SkyePharma PLC Deferred Share Bonus Plan (the "Plan") approvedby shareholders at the Company's Annual General Meeting held on 6th June 2001:- Michael Ashton 57,520Donald Nicholson 53,762 Under the rules of the Plan the Executive Directors have invested 100% of theirbonus (after the deduction of tax) relating to the year 2004 in ordinary sharesof the Company (the "Executive Shares") at a price per share of 64.5833 pence(the three day average prior to 2 February 2005). In addition, the Plan provides for the Company to allocate one Matching Share,subject to certain conditions, for every Executive Share that would have beenpurchased if the gross bonus had been invested in shares. This allocation issubject to the following conditions: • The retention of the Executive Shares for three years from the date of acquisition • The continuous employment of the Executive throughout the three year period • The Company's comparative Total Shareholder Return performance over the three year period In respect of the following Executive Directors the number of Matching Shares towhich those Executive Directors are conditionally entitled is: Michael Ashton 97,492Donald Nicholson 91,122 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L